Abstract
Thyroid hormones are transported across cell membranes by transmembrane transporter proteins, for example by members of the monocarboxylate transporter (MCT) and the L-type amino acid transporter (LAT) families. LATs consist of a light chain (e.g. LAT2) and a heavy chain (CD98), which is essential for their cell surface expression and functionality. The specificity of Lat2 for thyroid hormones and their metabolites and its role in their transport was not fully clear. This fact motivated us to establish a cell system to elucidate the uptake of thyroid hormones and their metabolites by mouse Lat2. The coinjection of cRNA coding for Lat2 and CD98 into Xenopus laevis oocytes resulted in a markedly increased level of 3,3′-diiodo-<smlcap>L</smlcap>-thyronine (3,3′-T2) and to some extent also enhanced T3 transport. To gain insight into properties of thyroid hormones and their metabolites transported by Lat2, we inhibited 3,3′-T2 uptake by various iodothyronine derivatives. T1 and T2 derivatives as well as 2-aminobicyclo-[2,2,1]-heptane-2-carboxylic acid strongly competed with 3,3′-T2 uptake. In addition, we performed T2 uptake measurements with the thyroid hormone-specific transporter MCT8. For both Lat2 and MCT8, Km values in a low micromolar range were calculated. We demonstrated that oocytes are a suitable system for thyroid hormone transport studies mediated by Lat2. Our data indicates that Lat2 compared to other thyroid hormone transporters prefers 3,3′-T2 as the substrate. Thus, Lat2 might contribute to the availability of thyroid hormone by importing and/or exporting 3,3′-T2, which is generated either by T3 inactivation or by rapid deiodinase 1-mediated rT3 degradation.
Journal Section:
Basic Thyroidology / Original Paper
References
1.
Bernal J, Nunez J: Thyroid hormones and brain development. Eur J Endocrinol 1995;133:390-398.
[PubMed]
2.
Zoeller TR, Dowling AL, Herzig CT, Iannacone EA, Gauger KJ, Bansal R: Thyroid hormone, brain development, and the environment. Environ Health Perspect 2002;110:355.
[PubMed]
3.
Silva JE: Thyroid hormone control of thermogenesis and energy balance. Thyroid 1995;5:481-492.
[PubMed]
4.
Visser WE, Friesema EC, Visser TJ: Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 2011;25:1-14.
[PubMed]
5.
Kinne A, Schülein R, Krause G: Primary and secondary thyroid hormone transporters. Thyroid Res 2011;4:S7.
[PubMed]
6.
Wirth EK, Roth S, Blechschmidt C, Hölter SM, Becker L, Racz I, Zimmer A, Klopstock T, Gailus-Durner V, Fuchs H: Neuronal 3′,3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci 2009;29:9439-9449.
[PubMed]
7.
Braun D, Kinne A, Bräuer AU, Sapin R, Klein MO, Köhrle J, Wirth EK, Schweizer U: Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells. Glia 2011;59:463-471.
[PubMed]
8.
Braun D, Wirth EK, Wohlgemuth F, Reix N, Klein MO, Gruters A, Kohrle J, Schweizer U: Aminoaciduria, but normal thyroid hormone levels and signalling, in mice lacking the amino acid and thyroid hormone transporter Slc7a8. Biochem J 2011;439:249-255.
[PubMed]
9.
Núñez B, de Mena RM, Obregon MJ, Font-Llitjós M, Nunes V, Palacín M, Dumitrescu AM, Morte B, Bernal J: Cerebral cortex hyperthyroidism of newborn Mct8-deficient mice transiently suppressed by Lat2 inactivation. PloS One 2014;9:e96915.
[PubMed]
10.
Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, Kühn LC: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem 1999;274:34948-34954.
[PubMed]
11.
Pineda M, Fernández E, Torrents D, Estévez R, López C, Camps M, Lloberas J, Zorzano A, Palacín M: Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 1999;274:19738-19744.
[PubMed]
12.
Broer A, Friedrich B, Wagner C, Fillon S, Ganapathy V, Lang F, Broer S: Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains. Biochem J 2001;355:725-731.
[PubMed]
13.
Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, Hennemann G, Visser TJ: Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology 2001;142:4339-4348.
[PubMed]
14.
Schmidt-Rose T, Jentsch TJ: Transmembrane topology of a CLC chloride channel. Proc Natl Acad Sci USA 1997;94:7633-7638.
[PubMed]
15.
Kinne A, Kleinau G, Hoefig CS, Grüters A, Köhrle J, Krause G, Schweizer U: Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem 2010;285:28054-28063.
[PubMed]
16.
Friesema EC, Ganguly S, Abdalla A, Fox JEM, Halestrap AP, Visser TJ: Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003;278:40128-40135.
[PubMed]
17.
Brown DD: A tribute to the Xenopus laevis oocyte and egg. J Biol Chem 2004;279:45291-45299.
[PubMed]
18.
Morimoto E, Kanai Y, Kim DK, Chairoungdua A, Choi HW, Wempe MF, Anzai N, Endou H: Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters. J Pharmacol Sci 2008;108:505-516.
[PubMed]
19.
Khunweeraphong N, Nagamori S, Wiriyasermkul P, Nishinaka Y, Wongthai P, Ohgaki R, Tanaka H, Tominaga H, Sakurai H, Kanai Y: Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties. J Pharmacol Sci 2012;119:368-380.
[PubMed]
20.
Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y: Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999;274:19745-19751.
[PubMed]
21.
Broer A, Hamprecht B, Broer S: Discrimination of two amino acid transport activities in 4F2 heavy chain-expressing Xenopus laevis oocytes. Biochem J 1998;333:549-554.
[PubMed]
22.
Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier P: Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 2002;16:2283-2296.
[PubMed]
23.
Tohyama K, Kusuhara H, Sugiyama Y: Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 2004;145:4384-4391.
[PubMed]
24.
Christensen HN, Handlogten ME, Lam I, Tager HS, Zand R: A bicyclic amino acid to improve discriminations among transport systems. J Biol Chem 1969;244:1510-1520.
[PubMed]
25.
Lanni A, Moreno M, Horst C, Lombardi A, Fernando G: Specific binding sites for 3,3′-diiodo-L-thyronine (3,3′-T2) in rat liver mitochondria. FEBS Lett 1994;351:237-240.
[PubMed]
26.
Lehmphul I, Brabant G, Wallaschofski H, Ruchala M, Strasburger CJ, Köhrle J, Wu Z: Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay. Thyroid 2014;24:1350-1360.
[PubMed]
27.
Jonas W, Lietzow J, Wohlgemuth F, Hoefig CS, Wiedmer P, Schweizer U, Köhrle J, Schürmann A: 3,5-Diiodo-L-thyronine (3,5-T2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male dietinduced obese mice. Endocrinology 2014;156:389-399.
[PubMed]
28.
Pietzner M, Lehmphul I, Friedrich N, Schurmann C, Ittermann T, Dörr M, Nauck M, Laqua R, Völker U, Brabant G: Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T2? Thyroid 2015;25:188-197.
[PubMed]
29.
Padron AS, Neto RAL, Pantaleão TU, de Souza dos Santos MC, Araujo RL, de Andrade BM, da Silva Leandro M, de Castro JPSW, Ferreira ACF, de Carvalho DP: Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues. J Endocrinol 2014;221:415-427.
[PubMed]
30.
Moreno M, de Lange P, Lombardi A, Silvestri E, Lanni A, Goglia F: Metabolic effects of thyroid hormone derivatives. Thyroid 2008;18:239-253.
[PubMed]
31.
Ball S, Sokolov J, Chin W: 3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro. J Mol Endocrinol 1997;19:137-147.
[PubMed]
32.
Smit J, Visser T: 37th annual meeting of The European Thyroid Association: abstracts - Leiden, The Netherlands, September 7-11, 2013. Eur Thyroid J 2013; 2(suppl 1):75-194.
33.
Mendoza A, Navarrete-Ramírez P, Hernández-Puga G, Villalobos P, Holzer G, Renaud J, Laudet V, Orozco A: 3,5-T2 is an alternative ligand for the thyroid hormone receptor β1. Endocrinology 2013;154:2948-2958.
[PubMed]
34.
Meier C, Ristic Z, Klauser S, Verrey F: Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J 2002;21:580-589.
[PubMed]
© 2015 European Thyroid Association Published by S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.
